Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers

BACKGROUND: Platinum-based combination therapy is the standard first-line treatment for women with advanced serous epithelial ovarian carcinoma (EOC). However, about 20 % will not respond and are considered clinically resistant. The availability of biomarkers to predict responses to the initial ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Lane, Denis, Matte, Isabelle, Garde-Granger, Perrine, Laplante, Claude, Carignan, Alex, Rancourt, Claudine, Piché, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486134/
https://www.ncbi.nlm.nih.gov/pubmed/26122176
http://dx.doi.org/10.1186/s12885-015-1511-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486134/
https://www.ncbi.nlm.nih.gov/pubmed/26122176
http://dx.doi.org/10.1186/s12885-015-1511-7

Ejemplares similares